Neutrophilic Dermatoses and Inflammatory Bowel Diseases

Displaying 1 - 6 of 6CSV
McKay, G. E., Coromilas, A., Liu, L., Shaw, K. S., Murphy, M., Punyamurthy, N., Soltero, K. M. S., Damsky, W., Wanat, K. A., Charrow, A. P., Rosenbach, M., Caplan, A., LaSenna, C. E., Arkin, L., & Shields, B. E. (2025). Interleukin‐12/23 and Interleukin‐23 Inhibitors for the Treatment of Cutaneous Crohn’s Disease: A Case Series From a Multi‐Institutional Registry. JEADV Clinical Practice. Portico. https://doi.org/10.1002/jvc2.615
Publication Date
Gordon, E. R., Chen, C., Adeuyan, O., Lapolla, B. A., Trager, M. H., Schreidah, C. M., Fahmy, L. M., & Geskin, L. J. (2024). Experiences of patients with cutaneous manifestations of monoclonal gammopathy of undetermined significance (MGUS): Insights from the first disease‐specific support group. JEADV Clinical Practice. Portico. https://doi.org/10.1002/jvc2.427
Publication Date
Panganiban, R. P., Tuan, A., Hart, M., Pelton, M., Mikhail, D., Akhtar, S., Bogale, K., Deiling, S., Zhou, S., Coates, M. D., Yochum, G. S., & Koltun, W. (2023). Pyoderma Gangrenosum Is Associated With Increased Risk of Inflammatory Pouch-Related Complications: A Retrospective Cohort Study. Crohn’s & Colitis 360, 5(3). https://doi.org/10.1093/crocol/otad024
Publication Date
Maniar, R., Gallitano, S. M., Husain, S., Moazami, G., Weiss, M. J., & Shu, C. A. (2023). Unusual Adverse Events in a Patient With BRAF-Mutated Non–Small Cell Lung Cancer Treated With BRAF/MEK Inhibition. Journal of the National Comprehensive Cancer Network, 21(3), 232–234. https://doi.org/10.6004/jnccn.2022.7084
Publication Date